vs
ExlService Holdings, Inc.（EXLS）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
ExlService Holdings, Inc.的季度营收约是LifeStance Health Group, Inc.的1.4倍（$542.6M vs $382.2M），ExlService Holdings, Inc.净利率更高（11.1% vs 3.1%，领先8.1%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 12.7%），ExlService Holdings, Inc.自由现金流更多（$106.5M vs $46.6M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 11.5%）
ExlService Holdings Inc.是全球知名的分析与数字解决方案服务商，服务覆盖保险、医疗健康、银行金融服务、媒体、零售等多个行业，总部位于纽约，在美国、欧洲、亚洲、拉美、澳大利亚、南非等地拥有超过5.4万名专业从业人员。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
EXLS vs LFST — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $542.6M | $382.2M |
| 净利润 | $60.2M | $11.7M |
| 毛利率 | 38.6% | — |
| 营业利润率 | 14.4% | 4.7% |
| 净利率 | 11.1% | 3.1% |
| 营收同比 | 12.7% | 17.4% |
| 净利润同比 | 18.9% | 264.1% |
| 每股收益（稀释后） | $0.38 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $542.6M | $382.2M | ||
| Q3 25 | $529.6M | $363.8M | ||
| Q2 25 | $514.5M | $345.3M | ||
| Q1 25 | $501.0M | $333.0M | ||
| Q4 24 | $481.4M | $325.5M | ||
| Q3 24 | $472.1M | $312.7M | ||
| Q2 24 | $448.4M | $312.3M | ||
| Q1 24 | $436.5M | $300.4M |
| Q4 25 | $60.2M | $11.7M | ||
| Q3 25 | $58.2M | $1.1M | ||
| Q2 25 | $66.1M | $-3.8M | ||
| Q1 25 | $66.6M | $709.0K | ||
| Q4 24 | $50.7M | $-7.1M | ||
| Q3 24 | $53.0M | $-6.0M | ||
| Q2 24 | $45.8M | $-23.3M | ||
| Q1 24 | $48.8M | $-21.1M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 37.8% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 37.4% | — |
| Q4 25 | 14.4% | 4.7% | ||
| Q3 25 | 14.4% | 2.0% | ||
| Q2 25 | 15.8% | -0.9% | ||
| Q1 25 | 15.7% | 0.5% | ||
| Q4 24 | 14.8% | 0.3% | ||
| Q3 24 | 14.7% | 0.0% | ||
| Q2 24 | 13.7% | -5.1% | ||
| Q1 24 | 14.1% | -5.6% |
| Q4 25 | 11.1% | 3.1% | ||
| Q3 25 | 11.0% | 0.3% | ||
| Q2 25 | 12.8% | -1.1% | ||
| Q1 25 | 13.3% | 0.2% | ||
| Q4 24 | 10.5% | -2.2% | ||
| Q3 24 | 11.2% | -1.9% | ||
| Q2 24 | 10.2% | -7.5% | ||
| Q1 24 | 11.2% | -7.0% |
| Q4 25 | $0.38 | — | ||
| Q3 25 | $0.36 | — | ||
| Q2 25 | $0.40 | — | ||
| Q1 25 | $0.40 | — | ||
| Q4 24 | $0.31 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.28 | — | ||
| Q1 24 | $0.29 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $328.4M | $248.6M |
| 总债务越低越好 | $298.6M | $282.8M |
| 股东权益账面价值 | $912.7M | $1.5B |
| 总资产 | $1.7B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.33× | 0.19× |
8季度趋势，按日历期对齐
| Q4 25 | $328.4M | $248.6M | ||
| Q3 25 | $390.1M | $203.9M | ||
| Q2 25 | $353.3M | $188.9M | ||
| Q1 25 | $331.4M | $134.3M | ||
| Q4 24 | $340.6M | $154.6M | ||
| Q3 24 | $325.8M | $102.6M | ||
| Q2 24 | $276.1M | $87.0M | ||
| Q1 24 | $246.2M | $49.5M |
| Q4 25 | $298.6M | $282.8M | ||
| Q3 25 | $354.8M | $284.6M | ||
| Q2 25 | $260.0M | $286.4M | ||
| Q1 25 | $307.3M | $288.2M | ||
| Q4 24 | $288.5M | $290.0M | ||
| Q3 24 | $344.7M | $287.3M | ||
| Q2 24 | — | $288.0M | ||
| Q1 24 | — | $288.8M |
| Q4 25 | $912.7M | $1.5B | ||
| Q3 25 | $952.4M | $1.5B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $1.0B | $1.5B | ||
| Q4 24 | $929.9M | $1.4B | ||
| Q3 24 | $907.6M | $1.4B | ||
| Q2 24 | $852.6M | $1.4B | ||
| Q1 24 | $803.3M | $1.4B |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.1B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.1B | ||
| Q1 24 | $1.4B | $2.1B |
| Q4 25 | 0.33× | 0.19× | ||
| Q3 25 | 0.37× | 0.19× | ||
| Q2 25 | 0.25× | 0.19× | ||
| Q1 25 | 0.30× | 0.20× | ||
| Q4 24 | 0.31× | 0.20× | ||
| Q3 24 | 0.38× | 0.20× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $117.4M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $106.5M | $46.6M |
| 自由现金流率自由现金流/营收 | 19.6% | 12.2% |
| 资本支出强度资本支出/营收 | 2.0% | 2.9% |
| 现金转化率经营现金流/净利润 | 1.95× | 4.93× |
| 过去12个月自由现金流最近4个季度 | $298.1M | $110.0M |
8季度趋势，按日历期对齐
| Q4 25 | $117.4M | $57.6M | ||
| Q3 25 | $120.7M | $27.3M | ||
| Q2 25 | $109.4M | $64.4M | ||
| Q1 25 | $3.2M | $-3.1M | ||
| Q4 24 | $105.3M | $62.3M | ||
| Q3 24 | $110.1M | $22.7M | ||
| Q2 24 | $74.9M | $44.1M | ||
| Q1 24 | $-21.9M | $-21.8M |
| Q4 25 | $106.5M | $46.6M | ||
| Q3 25 | $106.4M | $17.0M | ||
| Q2 25 | $95.0M | $56.6M | ||
| Q1 25 | $-9.7M | $-10.3M | ||
| Q4 24 | $95.3M | $56.0M | ||
| Q3 24 | $97.3M | $17.7M | ||
| Q2 24 | $62.8M | $39.0M | ||
| Q1 24 | $-33.1M | $-26.9M |
| Q4 25 | 19.6% | 12.2% | ||
| Q3 25 | 20.1% | 4.7% | ||
| Q2 25 | 18.5% | 16.4% | ||
| Q1 25 | -1.9% | -3.1% | ||
| Q4 24 | 19.8% | 17.2% | ||
| Q3 24 | 20.6% | 5.7% | ||
| Q2 24 | 14.0% | 12.5% | ||
| Q1 24 | -7.6% | -9.0% |
| Q4 25 | 2.0% | 2.9% | ||
| Q3 25 | 2.7% | 2.8% | ||
| Q2 25 | 2.8% | 2.2% | ||
| Q1 25 | 2.6% | 2.2% | ||
| Q4 24 | 2.1% | 1.9% | ||
| Q3 24 | 2.7% | 1.6% | ||
| Q2 24 | 2.7% | 1.6% | ||
| Q1 24 | 2.6% | 1.7% |
| Q4 25 | 1.95× | 4.93× | ||
| Q3 25 | 2.08× | 25.34× | ||
| Q2 25 | 1.66× | — | ||
| Q1 25 | 0.05× | -4.36× | ||
| Q4 24 | 2.08× | — | ||
| Q3 24 | 2.08× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
LFST
暂无分部数据
